These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2850326)

  • 1. A new low molecular weight heparin in the treatment of peripheral arterial disease.
    Palmieri G; Ambrosi G; Agrati AM; Ferraro G; Marcozzi S
    Int Angiol; 1988; 7(3 Suppl):41-7. PubMed ID: 2850326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcitonin on limb blood vessels in human obstructive arterial disease.
    Franchi F; Chiarini P; Matassi L; Strazzulla G; Scardi A; Righi D; Nuzzaci G
    Int J Clin Pharmacol Res; 1983; 3(2):115-28. PubMed ID: 6679513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local regulation of subcutaneous blood flow and capillary filtration in limbs with occlusive arterial disease. Studies before and after arterial reconstruction.
    Eickhoff JH
    Dan Med Bull; 1986 Jun; 33(3):111-26. PubMed ID: 3720362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
    Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
    Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A; Rouffy J
    J Mal Vasc; 1995; 20(1):21-7. PubMed ID: 7745355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.
    Jivegård L; Drott C; Gelin J; Groth O; Hensäter M; Jensen N; Johansson G; Konrad P; Lindberg B; Lindhagen A; Lundqvist B; Oden A; Smith L; Stenberg B; Thornell E; Wingren U; Ortenwall P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):190-8. PubMed ID: 15649728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
    Schütz RM; Teufel W; Glocke M
    Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
    Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
    Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.